Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11578126
Chimeric antigen receptor (CAR) comprising a CD19-binding domain
granted -
US 11576951
Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
granted -
US 11576984
Genetically modified mouse with humanized immunoglobulin heavy chain constant region genes and method of using
granted -
US 11576948
Long-acting VEGF inhibitors for intraocular neovascularization
granted -
US 11578078
Heterocyclic RIP1 inhibitory compounds
granted -
US 11578081
Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof
granted -
US 11578371
Biomarkers for predicting tumor response to and toxicity of immunotherapy
granted -
US 11576922
CD73 inhibitors
granted -
US 11576871
Formulations of cysteamine and cystamine
granted -
US 11576883
L-DOPA microbiome therapy
granted -
US 11576889
Methods of identifying and treating patients with HIF-2 inhibitor resistance
granted -
US 11576982
Nipah virus envelope pseudotyped lentiviruses and methods of their use
granted -
US 11576580
Apparatus, systems and methods for intraoperative imaging
granted -
US 11578103
Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays
granted -
US 11578338
Hemipteran active insecticidal protein
granted -
US 11576924
Compounds for the prevention and treatment of diseases and the use thereof
granted -
US 11578062
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
granted -
US 2023040008
ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
granted -
EP 4125971
BAKTERIENSTÄMME, ZUSAMMENSETZUNGEN DAVON UND VERWENDUNG DAVON IN EINEM VERFAHREN ZUR BEHANDLUNG VON VITAMIN-D-MANGEL UND DAMIT ASSOZIIERTEN ERKRANKUNGEN
granted -
US 11571444
Enhancement of MSC immunomodulatory properties by treprostinil
granted -
US 11572408
Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent
granted -
US 11571482
Human antibodies to S. aureus Hemolysin A toxin
granted -
US 11572568
Regulating alkaloids
granted -
US 11572588
Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.